Part I: Anticipating the Impact of EU Regulatory Change on Life Sciences Companies

December 1, 2022 9:00am

Recent and ongoing European regulatory changes will affect every originator and biosimilar company that currently sells or sponsors products in the European Union and the UK. The regulatory landscape is transforming so rapidly that that companies must track and monitor these developments or risk the license-to-operate.

While timelines continue to waver, manufacturers, distributors, providers, and counsel must consider the implications of these regulations and take a proactive approach to dealing with regulatory change.

Topics of discussion will help you:

  • Understand legislative reforms that will impact biosimilar regulation within Europe
  • Learn how companies can adapt their processes and systems to these new systems in order to comply
  • Appreciate which innovative process and technology solutions can help you achieve readiness success